When pharmaceutical facilities can cost hundreds of millions of euros, getting the numbers right from the outset is critical. Boehringer Ingelheim explains how it is combining AI, historical project data and robust governance.
EpilepsyGTx and ClearPoint Neuro have announced a partnership to support the targeted delivery of EpilepsyGTx’s lead gene therapy candidate, EPY201, for focal refractory epilepsy (FRE).
Brenntag has announced a new strategic partnership with Evonik REXIM for the distribution of its GMP grade amino acids to the pharmaceutical and biopharmaceutical markets in Europe, effective 1st July 2026.
Kindeva, a drug delivery Contract Development and Manufacturing Organisation, has announced the appointment of Brok Weichbrodt as chief transformation officer to accelerate growth as the company enters the next phase of its value creation plan.
Hansa Biopharma and SERB S.A. has announced required regulatory approvals have been obtained and that the previously announced exclusive licensing transaction with SERB has closed.
Corten Capital and Ampersand Capital Partners (“Ampersand”) have announced the completion of their acquisition of Beacon Intelligence from the Hanson Wade Group, backed by Graphite Capital.
